Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

How We Came to Start the Open Synthesis Network

| Ben Perry | 4 min read

This is the story of how DNDi put forward a new model for collaborative, open science.

Discovery & Development Drug Discovery

Meet the Protein Decoder

| Angus Stewart | 4 min read

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

Discovery & Development Clinical Trials

A LEAP of Faith

| Angus Stewart | 6 min read

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

Discovery & Development Drug Discovery

Reaching for the Moon

| Angus Stewart | 6 min read

How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2

Discovery & Development Clinical Trials

Video: How Can Pharma Improve Clinical Trials?

| Maryam Mahdi

How pharma is working to develop efficient and patient-centric trials.

Discovery & Development Clinical Trials

The Cancer Trial Seeing Incredible Results

| Stephanie Sutton | 2 min read

A trial for a new immunotherapy is seeing incredible results for rectal cancer patients.

Discovery & Development Drug Delivery

First Contact

| Angus Stewart | 5 min read

An inside view on the San Diego company working to bring drug delivering contact lenses to market.

Discovery & Development Dosage Forms

The New Filmmakers

| Angus Stewart

This Scottish company is developing a thin film that could improve medicine adherence in the elderly

Discovery & Development Clinical Trials

Data Damage

| Angus Stewart

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Discovery & Development Clinical Trials

Trials on Trial

| Angus Stewart

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register